Delivering direct acting antiviral therapy for hepatitis C to highly marginalised and current drug injecting populations in a targeted primary health care setting

P Read, R Lothian, K Chronister, R Gilliver… - International Journal of …, 2017 - Elsevier
Background The Kirketon Road Centre (KRC) is a community-based public health facility in
Sydney, Australia, that provides healthcare to people who inject drugs (PWID), including …

Treatment adherence and support for people who inject drugs taking direct‐acting antiviral therapy for hepatitis C infection

P Read, R Gilliver, J Kearley, R Lothian… - Journal of viral …, 2019 - Wiley Online Library
A community‐based public health facility in Sydney, Australia, the Kirketon Road Centre (KRC),
provides health care to people who inject drugs (PWID), homeless and other …

[HTML][HTML] Single-visit hepatitis C point-of-care testing, linkage to nursing care, and peer-supported treatment among people with recent injecting drug use at a peer-led …

J Grebely, R Gilliver, T McNaughton, A Conway… - International Journal of …, 2023 - Elsevier
Background Point-of-care hepatitis C virus (HCV) RNA testing can facilitate single-visit
diagnosis and treatment. This study evaluated a single-visit test and treat intervention integrating …

[HTML][HTML] Hepatitis C virus transmission between eight high-income countries among men who have sex with men: a whole-genome analysis

…, V George, C Gerlach, Y Gilleece, R Gilliver… - The Lancet …, 2023 - thelancet.com
Background Microelimination of the hepatitis C virus (HCV) among men who have sex with
men (MSM) could be complicated by continuous external introductions and the emergence of …

High Effectiveness of Broad Access Direct‐Acting Antiviral Therapy for Hepatitis C in an A ustralian Real‐World Cohort: The REACH‐C Study

…, W Lam, RP Dahal, P Habel, R Gilliver… - Hepatology …, 2022 - Wiley Online Library
Australia was one of the first countries with unrestricted access to government subsidized
direct‐acting antiviral (DAA) therapy for adults with chronic hepatitis C virus. This study …

[HTML][HTML] Awareness of HCV status and preferences for testing and treatment among people with recent injecting drug use at a peer-led needle and syringe program …

A Conway, P Read, R Gilliver, T McNaughton… - Viruses, 2022 - mdpi.com
Background: New technologies and therapies allow the possibility of a single-visit test and
treat model for hepatitis C virus (HCV), addressing some of the barriers to care faced by …

Retreatment for hepatitis C virus direct‐acting antiviral therapy virological failure in primary and tertiary settings: The REACH‐C cohort

…, W Lam, RP Dahal, P Habel, R Gilliver… - Journal of viral …, 2022 - Wiley Online Library
Virological failure occurs in a small proportion of people treated for hepatitis C virus (HCV)
with direct‐acting antiviral (DAA) therapies. This study assessed retreatment for virological …

Designing, implementing and evaluating the overdose response with take‐home naloxone model of care: An evaluation of client outcomes and perspectives

…, M Bravo, P Read, ME Harrod, R Gilliver… - Drug and alcohol …, 2020 - Wiley Online Library
Introduction and Designs Take‐home naloxone (THN) interventions are an effective response
to preventing overdose deaths, however uptake across Australia remains limited. This …

Patient-reported outcomes during and after hepatitis C virus direct-acting antiviral treatment among people who inject drugs

…, O Cerocchi, M Lacalamita, V Fragomeli, R Gilliver… - Value in Health, 2023 - Elsevier
Objectives People who inject drugs (PWID) are at a high risk of hepatitis C virus (HCV) infection.
HCV cure is associated with improved patient-reported outcomes (PROs), but there are …

The Overdose Response with Take Home Naloxone (ORTHN) project: Evaluation of health worker training, attitudes and perceptions

…, M Bravo, L Mills, A Malcolm, R Gilliver… - Drug and Alcohol …, 2022 - Wiley Online Library
Introduction Naloxone is a life‐saving medication that reverses opioid overdose; naloxone
can be provided on a ‘take‐home’ basis so naloxone can be administered outside of the …